Aaron G. Maestri, Ph.D., Emba Email & Phone Number

Palo Alto, CA, US

Member of the Global Directorial Board

Seattle, US

Paris La Défense Cedex, FR

FR

AUDAXION Therapeutics is a stealth mode start-up biopharma corporation launched from a validated target and lead candidate - namely the APJ-Apelin (latter endogenous peptide) molecular network. AUDAXION was forged out of Stanford in part from the proven biomedical innovations in commercialized blockbusters (Remicade, >$90B sales to date; J&J; and Tysabri.

AUDAXION is partnering with many of the world-leading Physician-Scientist-Clinicians & Inventors from Stanford University to develop an evolutionary, holistic solution for the treatment of neurodegenerative (e.g. Dementias - ALS and ALZ) and NVD disorders (e.g. strokes and TIAs). Our mission involves a curative approach to the greatest healthcare challenge.

Brenes, Sevilla, ES

AVIVE is leveraging best-in-class / only-in-class products spearheaded by a Clinical-stage, CVMET-focused program and well balanced by breakthrough IND-stage assets that aggressively treat CV- as well as Metabolic-diseases. We have secured dominate IP-positions for revolutionary therapies that are highly efficacious but also are geared, for instance, to.

Brenes, Sevilla, ES

We are a biopharmaceutical company developing novel medicines to combat the deadliest conditions facing the world today including cardiovascular and metabolic diseases. Our therapeutic arsenal consists of small- and large-molecules along with cell therapies.A Singular Passion for Protecting Lives:We are a group of “difference makers”–experienced.

Brenes, Sevilla, ES

AVIVE, Inc. is a clinical-stage company with a novel and meaningful therapeutic solution for Heart Failure (HF) treatment across myriad HF stages inclusive of our proposed first-in-class post-Myocardial Infarction (p-MI) indication. The therapeutic solution is based on years of R&D efforts achieved by several leading cardiology and formulation experts at.

London, England, GB

Scientific and Biomedical Directing Advisor to the Leadership due to my expertise in the Group Eight Metals: Iron, Ruthenium, and Osmium; inclusive of further expertise with regards to the mining, worldwide utilization across industries, and refining of Gold, Platinum, Palladium, and Rhenium.

US

Operating Director co-assisting the Managing Directors in providing evaluations ranging from myriad technology fields - Biotechnology to Pharmaceutical to de novo next-gen batteries (Li-Mg-X alloys) in the support of the coming Electrification Economy to Biofuels, Nuclear Chemistry, and next-gen Nuclear Reactors for Cleantech - overall goal to aid in the.

Chiral chemicals are essential for human living from amino acids as nutraceuticals to drugs to pesticides to flavors and fragrances and myriad other chemical products. Approximately 300 billion tons of chiral chemicals are produced each year consuming trillion tons+ of solvents. This solvent consumption creates an enormous burden on our environment and.

Palo Alto, CA, US

Visiting Research Scientist within the Department of Medicine (DOM) at Stanford University starting for the 2015 academic year and partnering with the Director of the BioADD (Biomaterials and Advanced Drug Delivery) as a Rx- as well as Dx-solutions driven laboratory and the latter entity collaborates with myriad Professors/PIs, Researchers, and key.

Milpitas, CA, US

Aspira Scientific Group was conceived by four chemists with uniquely tailored, yet synergistically powerful expertise sets in March of 2013, launched with seed funds by June, and is a science-centric ecosystem dedicated to empowering researchers to exceed their aspirations in chemical and biological R&D fields. In addition with have assembled a robust.

South San Francisco, California, US

Business Manager, at Genentech for our parent firm; since Genentech as of 2011 is a fully integrated Member of the Roche Group of Companies. My core strategic alliances role required that my responsibilities were to be focused in our Research & Early Development (gRED) Division and much cross-fertilization occurred during February via external piloting.

Milpitas, CA, US

Aspira Scientific Group's client-partnership motto is “Collaborate Locally, Commercialize Globally”™. As an R&D innovation-driven and customer-first corporation, Aspira provides a broad, integrated portfolio of services and products that are designed to best assist consumers in exceeding deliverables' timeframes and lowering the cost of the translational.

New York, NY, US

Kaiseraugst, AG, CH

Co-initiated collaboration meetings between the Biopharma Founders with funding, drug development (CROs), regulatory organizations (EMEA & FDA), and gene therapy and cell therapy biotech firms. Transposagen was in the enviable position of being the first biopharma entity to produce "foot-print" free DNA editing using our proprietary PiggyBac(TM) platform..

Andheri (E), Mumbai, IN

Arch Pharmalabs is a global Top 10 "Pure-Play" small-molecule focused CMO. My Directorship was focused mainly on the North American market by providing broad CMC partnering solutions to clients representing key industry biotechnology players. Coordinated Arch’s outsourcing product management, M&A, and worldwide growth strategy on 3 continents for the.

Waltham, MA, US

Secured and drove preclinical, bio-analytical, & clinical drug product development business opportunities with Western U.S. clients in the greater pharmaceutical and veterinary industries. Effectively built fully integrated deals inclusive of successful bid defenses with U.S. colleagues comprised of GMP and Phases II-IV clinical trial support in nearly all.

Albany, NY, US

Built and managed a $10M+ territorial division, which prior to 2007 was at ca. $6M. Invoiced revenue through the first 3 quarters of 2008 was in excess of $7M; closed sales were higher at >$11M. This new business bolstered our commercial capacity, client trust, & helped boost stock valuation going into fiscal 2009. Procured development and API production.

Darmstadt, DE

Established, fostered, and managed new custom chemical and biological manufacturing business opportunities with clients in the pharmaceutical/biotech industries, after being internally promoted from marketing to business development. Led Sigma Aldrich's SAFC-Pharma business activities by transferring API projects from virtual through to specialty.

US

I took on the role of the host of The Capital Grill in Milwaukee in the Fall of 2005, which was THE place for fine dining in the city only one-block downtown from the NBA's Milwaukee Bucks (and their 28K capacity, newly minted stadium). This was a comparatively prestigious position given to trusted employees, and since the Capital Grill Management trusted.

Darmstadt, DE

1) Managed $35M+ in company revenue worldwide. ROI: 100+ licensed & marketed products of which approximately 25 led to >$500K turnover. Responsible for the development and licensing of new catalysts and fine chemicals via directing internal R&D projects as well as building effective partnerships with key scientific leaders on 3 continents. Project leader.

Philadelphia, PA, US

Co-developed new methodologies in the field of zinc-mediated catalysis: This groundbreaking project has led to multiple publications for the Walsh group and has engendered a general, complementary route to valuable intermediates utilized in the expeditious construction of synthetic & natural product-based drugs by the pharmaceutical industry. This creative.

Notre Dame, IN, US

Dissertation: “Part I: Sterically Hindered Polyphenols and their Titanium Complexes: Synthesis, Structure, and Dynamics; Part II: An Investigation into the Reactivity and Mechanism of Group VIII Metal Nitrides with Alkenes." Ph.D. Advisor: Dr., Prof. Seth N. Brown.1) Nobel Laureate-affiliated Brown group research in early through late-transition metal.

US

The History of GTE - The Evolution of One of America's Great Corporations (Thomas E. McCarthy) 1990

Midland, Michigan, US

Investigated and designed potential applications of two-part polymer foams in the automotive industry as an R&D intern during the SUMMERS of 1996/97. Designed new methods for foam dispensing in car cavities, leading to stiffer and quieter transportation. Performed stress tests on new car windshield adhesives to determine exact limits of failure.

Amsterdam, NL

London, England, GB

New York, NY, US

Professionally trained, classical artist tutored by my Italian Father at the age of four to: 1) begin painting classical works of art; mostly oil on canvas and some watercolours. Painted mostly landscapes, still-life, and portraits for a decade, while J. Walter Thompson's Executive Director of it's Visual Ad Service Division for the Big Three Auto Makers.

Visiting Research Fellow (In Bioadd Within The Cvi) & By Courtesy Was A Spark Biomedical Advisor, Pharmaceutics And Drug Design

Executive Curricula - Stanford Gbs, Executive Leadership Courses In M&A, Global Marketing, And Innovative Negotiations

Nih Postdoctoral Fellowship:, Organic Chemistry, Asymmetric Catalysis, Novel Metal-Mediated Reactions, And Total Synthesis

Penn Coursework Towards A Llm Degree: Foci In Corporate M&A, Patent/Ip Law & Copyrights + Trademarks, Copyrights, Trade Secrets, Ip Case Law; & Issuance, Protection And Extension(S) In Biotech Ip.

Ph.D., De Novo Metal-Mediated Reactions: [4+1] & [2+2] Organometallic Syntheses, Mechanisms, & Organic Rxns

Bachelor Of Science - Bs, Inorganometallic Chemistry

Started College Studies Early At Uofm With Scholarships During The '93 Summer, Attended Collegiate Chemistry Courses Solely During Two Summer Months (Cf. Below).

Troy High School (Ths) Diploma With Nhs Honors, Foci In Ap Chemistry, Ap English, & Advanced Physics

Executive Mba, International Business